---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-018565"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T06:31:29.631059+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nutex Health Q3 revenue $62.7M, up 121% YoY; Adj. EBITDA $1.3M; guides five new hospitals in 2024

## Summary
- Net loss attributable to Nutex Health $(5.5)M; Q3 2022 loss $(412.2)M included $398M goodwill impairment.
- Adjusted EBITDA of $1.3M; net cash from operating activities of $2.0M in Q3 2023.
- Expects to open five new micro-hospitals in 2024; raised $4.4M from $15M private offering through Nov. 6, 2023.
- Appointed Josh DeTillio as COO on Sept 5, 2023; acquired two Florida IPAs with 4,400 managed care patients.
- Cash and cash equivalents of $26.8M as of Sept 30, 2023; total assets $479.6M.

## SEC filing metadata
- accession: 0001558370-23-018565
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000155837023018565/0001558370-23-018565-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000155837023018565/nutx-20231109x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-018565
- JSON: https://secwatch.observer/filing/0001558370-23-018565.json
- Plain text: https://secwatch.observer/filing/0001558370-23-018565.txt

## Key facts
- Earnings Releases
  Nutex Health Inc. reported the three months and nine months ended September 30, 2023 results: revenue $62.7 million, net income Net loss attributable to Nutex Health of $(5.5) million in Q3 2023 and $(14.2) million for the first nine months of 2023.
  - Period: the three months and nine months ended September 30, 2023
  - Revenue: $62.7 million
  - Net income: Net loss attributable to Nutex Health of $(5.5) million in Q3 2023 and $(14.2) million for the first nine months of 2023
  - Result: reported results
  source text: is furnished as Exhibit 99.1 to this Current Report on Form 8-K. --- EX-99.1 (EX-99.1) --- NUTEX HEALTH reports THIRd quarter 2023 financial results ​ ● NET revenue of $62.7 million ● NET CASH FROM OPERATING ACTIVITIES OF $2.0 MILLION ● Company expects to open FIVE NEW MICRO-HOPITALS IN 2024 ​ HOUSTON, TX − (PRNewswire) – November 9, 2023 – Nutex Health Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000155837023018565/0001558370-23-018565-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.